Gastrointestinal Malignancies
Conditions
Interventions
the high SVI group:None
the low SVI group:None
Sponsors
Linyi Tumor Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Patients with pathologically confirmed, postoperative stage II-III colorectal or gastric cancer treated with oxaliplatin-containing adjuvant chemotherapy.
Exclusion criteria
Exclusion criteria: 1.The exclusion criteria were as follows: 1) having received less than 3 months of postoperative adjuvant chemotherapy; 2. Incomplete clinical data, laboratory results, or imaging studies; 3. Development of metastasis during adjuvant therapy; 4. Administration of additional chemotherapy drugs; 5. A history of splenectomy; 6. A history of liver cirrhosis, chronic liver disease, or prior liver surgery; 7. Pre-existing hematological diseases that cause platelet abnormalities.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| aspartase aminotransferase AST to alanine aminotransferase ALT ratio,AAR;fibrosis index based on the 4 factor,FIB-4;r-glutamyl transpeptidase-to-pialelet ratio,GPR;aspartase aminotransferase to platelet retio index,APRI;the volum of spleen; | — |
Countries
China
Contacts
Public ContactMeng Liu
Linyi Tumor Hospital
Outcome results
None listed